By: Mark Leiser From: healio.com Preoperative MRI served as a valuable complement to conventional imaging for determining extent of breast cancer and detecting additional lesions, according to study results presented at Miami Breast Cancer Conference. The approach appeared particularly beneficial for younger patients, results showed. Preoperative breast MRI can be used in addition to ultrasound and mammography to help inform …
Extent of sentinel lymph node biopsy influences lymphedema risk
By: Mark Leiser From: healio.com A higher number of resected lymph nodes increased the likelihood for lymphedema after sentinel lymph node biopsy, according to study results presented at Miami Breast Cancer Conference. The association was most apparent among patients who had more than five lymph nodes resected. “In clinical practice, expanding close follow-up and early education for lymphedema is the …
The FDA Approves Fourth Herceptin Biosimilar
By: Gina Columbus From: curetoday.com The Food and Drug Administration (FDA) has granted an approval to Trazimera (PF-05280014; trastuzumab-qyyp), a Herceptin (trastuzumab) biosimilar, to treat patients with HER2-overexpressing breast cancer as well as HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. This marks the fourth approval by the FDA for a trastuzumab biosimilar. The decision was based on findings of a …
Rare lymph node transplant reduces breast cancer survivor’s lymphedema swelling by half
Source: beaumont.org Beaumont microsurgeon one of a few in state performing procedure Sherry Boston survived breast cancer, a double mastectomy, chemotherapy, radiation treatments and breast reconstruction. But, the 49-year-old never expected a swollen arm would cause her so much long-term discomfort. “The swelling kept getting worse,” Boston said. “I wore a therapeutic sleeve during the day, which provided some temporary …
Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells
Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, announced today that it will introduce a new semi-automated assay workflow utilizing the CELLSEARCH® and DEPArrayTM platforms to enumerate and characterize circulating multiple myeloma cells (CMMC) from peripheral blood samples.** …
New strategy to tackle “don’t eat me” signal on cancer cells
Source: Netherlands Cancer Institute Myeloid immune cells kill cancer cells by eating them but cancer cells prevent this from happening by giving out a ‘do not eat me’ signal. Led by immunologists Ton Schumacher (Netherlands Cancer Institute and Oncode) and Ferenc Scheeren (Leiden University Medical Center), researchers from various research institutes have discovered a new method to inhibit the ‘don’t …
Immigrant Asian American women may be at higher risk for breast cancer
By: Tess Eyrich From: ucr.edu Immigrant Asian American women may be at higher risk for breast cancer Overall, breast cancer rates in the United States have stabilized since the 2000s. But according to the results of a new study led by a researcher from the University of California, Riverside, a subset of women living in the U.S. may be at …
Hospitals will be moving to digital pathology: Study
By:Tim Sandle From: digitaljournal.com The adoption of digital pathology technology is expected to increase during the next decade and the main adopters of this technology will be healthcare organizations, such as hospitals and diagnostic laboratories, according to a new report. As well as digital technologies in general, the healthcare sector will be enhancing digital images with artificial intelligence to help …
5 reasons you should put physicians in charge of hospitals
By: Edward R. Mariano, MD From: kevinmd.com Putting physicians in charge of hospitals seems like a no-brainer, but it isn’t what usually happens. A study published in Academic Medicine states that only about four percent of hospitals in the United States are run by physician leaders, which represents a steep decline from 35 percent in 1935. In the most recent …
Subcutaneous Herceptin Combo Therapy for Certain Breast Cancer Patients Granted FDA Approval
By: Jennifer Barrett From: pharmacytimes.com Officials with the FDA have approved trastuzumab and hyaluronidase-oysk (Herceptin Hylecta, Genentech) subcutaneous injection for certain patients with HER2-positive early and metastatic breast cancer, according to a press release. Trastuzumab and hyaluronidase-oysk is indicated for patients with early disease in combination with chemotherapy, and metastatic disease in combination with paclitaxel, or alone in patients who …